Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

FDA highlights risks of evaluating blood pressure with unauthorized medical devices
The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated.
Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes
Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.
Health systems use AI to target patients who may have elevated Lp(a) levels
"We can start helping people right now, and it would be meaningful if we can raise more awareness to reduce the burden of CVD," explained Katherine Wilemon, founder and CEO of the Family Heart Foundation.
Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?
Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.

Cardiovascular disease still the No. 1 cause of death in the world

A new global report, based on data from 204 different countries and territories, has been published in full in the Journal of the American College of Cardiology.

Treatments for rheumatoid arthritis, Parkinson’s disease linked to cardiovascular benefits

New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.

Alternative therapies for heart failure: Health experts detail the good, the bad and the unknown

A new scientific statement from the American Heart Association examined the potential impact of many therapies, including fish oil supplements, lily of the valley and yoga.

DASH diet reduces long-term risk of heart disease

Following the DASH diet is associated with key health benefits, according to a new analysis published in the American Journal of Cardiology.

wearable device heart health ECG SCG ultra soft University of Missouri Zheng Yan, PhD

New ‘ultra-soft’ wearable device uses ECG, SCG results to monitor heart health

The new-look device, still under development, is designed to be worn for weeks at a time.

Seaweed molecules could lead to big improvements for heart surgery patients

“There is a crucial need to develop synthetic vascular graft materials that will increase the rate of long-term functions,” one researcher said. Could materials derived from seaweed help fill that need?

doctor fruits vegetables vegetarian diet

Cardiologist urges physicians to promote plant-based diets: ‘We owe it to the profession, our patients and the planet’

The authors of a new commentary in the American Journal of Cardiology argued that well-balanced plant-based diets are good for the heart and good for society as a whole.

Adding extra salt to your food at the table associated with a greater risk of CVD, heart failure

Yes, even a little additional salt can make a big impact on a person's cardiovascular health. The full analysis was published in the Journal of the American College of Cardiology.

Heart Health

FDA highlights risks of evaluating blood pressure with unauthorized medical devices

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes

Health systems use AI to target patients who may have elevated Lp(a) levels

Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?